Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > More eyes on TH

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Feb 25, 2021 6:20pm

110 Views

Post# 32667167

RE:RE:RE:More eyes on TH

Do you know if views and number of viewers are the same?
I still think that the number does not make sense but thx for sharing

archeo753 wrote: The top 10 views list comes as part of a daily email news update from Stockhouse after market close. I'm not sure but think I was automatically subscribed when I signed up to Stockhouse.

palinc2000 wrote: I was not aware that the number of views was available,,,Where do you see this ?
Seems very high ......